SCHEMBL29909251

SCHEMBL29909251

c1ccc(N(CC2CC2)c2nc3nncn3c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
CREBBP Q92793 1/20 0.34
FGFR1 P11362 3/20 0.34
FGFR2 P21802 3/20 0.34
FGFR3 P22607 3/20 0.34
KDR P35968 3/20 0.34
FGFR4 P22455 2/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
JAK3 P52333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23577922 1.00 MAPT (0.34) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL23577173 0.95 SMN1; SMN2 (0.35) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL29909483 0.95 SMN1; SMN2 (0.35) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL23577189 0.94 CRY1 (0.37) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL29909554 0.94 CRY1 (0.37) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL23576877 0.92 ALOX15 (0.33) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL29909161 0.92 ALOX15 (0.33) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL29909525 0.87 FGFR1 (0.33) MAPTSMN1; SMN2FGFR1FGFR2FGFR3
SCHEMBL23576668 0.87 FGFR1 (0.33) MAPTSMN1; SMN2FGFR1FGFR2FGFR3
SCHEMBL30961049 0.84 ALOX15 (0.43) MAPTALDH1A1KDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12054490-B2 Diacylglycerol kinase modulating compounds GILEAD SCIENCES, INC. (US) 2024-08-06 US disclosed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12054490-B2 Diacylglycerol kinase modulating compounds DGKG, DGKB, DGKK MAPT 4206/4885ALDH1A1 4095/4885KDM4E 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.